Morsi M. Mahmoud; Kumar Sridharan; Henry Colorado; Amar S. Bhalla; J. P. Singh; Surojit Gupta; Jason Langhorn; A Jitianu John Wiley & Sons Inc (2018) Kovakantinen kirja
Ahmed M. Abdel-Azeem (ed.); Vijai K. Gupta (ed.); Bhim P. Singh (ed.); Lobna Hajji-Hedfi; Yousra A. El-Maradny; Soum Ghosh Springer (2026) Kovakantinen kirja
Springer Sivumäärä: 180 sivua Asu: Kovakantinen kirja Painos: 2002 Julkaisuvuosi: 2002, 30.09.2002 (lisätietoa) Kieli: Englanti Tuotesarja:Falk Symposium 126
In recent years there has been an increasing need for transplantation, but the number of donor livers available has increased only slightly, despite intensive public relations activities. New concepts in the field of transplantation, for instance the transplantation of living donor organs or the splitting of organs, are urgently required, to safeguard the treatment of patients with severe liver disease. The development and clinical application of cell therapy for patients with liver disease could soon present a significant enhancement of the therapeutic options. The aim of such cell therapy is to repair or improve the biological function of the chronically and acutely damaged liver. Even though systematic trials are not available, individual case reports and small series already show promising clinical results.
Present concepts of cell therapy for liver diseases based on the use of primary hepatocytes have recently been considerably extended through new data on the biology of stem cells. The adult haematopoetic stem cell as a pool for hepatocyte grafts - what would be the perspectives for the clinical application?
